Skip to content
Screener

Asset Entities ASST Corporate & Other — Operating Income (Loss)

Other segment segments

Medical Device
-$5.22M
Asset Management
-$2.16M-14.9%

Similar metrics at other companies

Beneficient logo
BENFCorporate & Other — Operating Income (Loss)
$35.83M+501%
AT&T logo
TCorporate & Other — Operating Income (Loss)
-$868M-42.3%
Starbucks logo
SBUXCorporate and Other — Operating Income (Loss)
-$587.5M-23.9%
Federal Signal logo
FSSCorporate — Operating Income (Loss)
$13M+32.7%
DocGo logo
DCGOCorporate — Operating Income (Loss)
-$14.75M+16.6%
Civeo logo
CVEOCorporate, other and eliminations — Operating Income (Loss)
-$5.18M+15.5%

Other financials

Income statement

See full
Revenue$2.9M+1,597%
Operating income-$258.2M-6,899%
Net income-$257.6M-2,803%
EPS (diluted)-$3.77+2.3%

Balance sheet

See full
Cash & equivalents$145.5M+1,053%
Total debt$3.3M
Total equity$646.2M+5,929%
Total assets$1.4B+42,111%

Cash flow

See full
Operating cash flow-$8.4M-90.0%
CapEx--100%
Free cash flow-$31.0M-450%

Valuation

See full
Market cap$1.04B+1,775%
Enterprise value$893.12M
P/S90.5×+17.9×

Profitability

See full
Operating margin-7,209.4%-16,069pp
Net margin-8,256.2%-20,690pp
FCF margin-3,856.7%

Returns & leverage

See full
Return on equity-287.5%-4.6pp
Debt / equity
Current ratio7.6×+2.9×

Where this comes from

Reported directly by Asset Entities in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Asset Entities’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 7:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054985
Line itemSuccessor / Three Months Ended June 30, 2026Predecessor / Three Months Ended June 30, 2025
Net unrealized loss on investments in preferred equity, at fair value(5,962)
Other investment loss(2,801)
Total investment losses(236,794)
Net operating loss(258,249)(3,690)
Other income/(expense):
Other income955252
Interest expense on long-term notes payable, at fair value(40)
Change in fair value on long-term notes payable, at fair value(299)

Item 1. Consolidated Financial Statements

FAQ

What is Asset Entities's corporate & other — operating income (loss)?
Asset Entities (ASST) reported corporate & other — operating income (loss) of -$250.88M in Q2 2026.
How has Asset Entities's corporate & other — operating income (loss) changed year-over-year?
Asset Entities's corporate & other — operating income (loss) decreased by 13730.1% year-over-year, from -$1.81M to -$250.88M.
What does corporate & other — operating income (loss) mean?
Calculated as the total revenue of the Corporate and Other segment minus its total operating expenses. This metric represents the core profitability of the segment before accounting for interest, taxes, or non-operating items. It is the primary indicator of the segment's ability to generate profit from its own operations.

Ask your AI about Asset Entities's corporate & other — operating income (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude